U.S. market Closed. Opens in 1 day 11 hours 15 minutes

INMB | INmune Bio, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Revenue155.00K374.00K181.00K10.92K77.69MN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit155.00K374.00K181.00K10.92K77.69MN/AN/AN/AN/A
Operating Expenses29.90M26.32M29.33M12.24M9.30M12.44M981.48K227.49K48.87K
Selling, General & Admin9.62M9.26M8.79M6.32M6.02M11.33M546.12K126.00K48.87K
Research & Development20.27M17.07M20.54M5.92M3.28M1.11M435.36K101.50KN/A
Other Operating ExpensesN/A-1.35M-1.19M128.52KN/AN/A-6.00N/AN/A
Operating Income-29.74M-25.95M-29.15M-12.23M-7.76M-12.44M-981.48K-227.49K-48.87K
Other Expenses / Income-267.00K-1.35M-1.19M129.00K77.69KN/A149.99K-50.00KN/A
Before Tax Income-30.01M-27.30M-30.34M-12.10M-7.68M-12.44M-831.49K-277.49K-48.87K
Income Tax ExpensesN/A1.35M-29.15M-12.23M1.46M-161.14K-1.13M-177.49KN/A
Net Income-30.01M-28.65M-30.34M-12.10M-9.14M-12.44M-831.49K-277.49K-48.87K
Interest ExpensesN/A1.35MN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding17.98M17.93M16.13M11.99M10.27M11.22M11.22M11.22M11.22M
Diluted Shares Outstanding17.98M17.93M16.13M11.99M10.27M11.22M11.22M11.22M11.22M
EBITDAN/AN/AN/AN/AN/AN/A149.99K-50.00K146.60K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-30.01M-25.95M-59.49M-24.33M-7.68M-12.60M-1.96M-454.98K-48.87K
EBIT Margin-19,360.00%-6,938.77%-32,869.06%-222,857.81%-9.88%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙